search
Back to results

Far Infrared Radiation Treatment for Prostate Cancer

Primary Purpose

Prostatic Neoplasms

Status
Unknown status
Phase
Phase 1
Locations
Canada
Study Type
Interventional
Intervention
Far Infrared Radiation
Sponsored by
GAAD Medical Research Institute Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Prostatic Neoplasms focused on measuring Tumors or cancer of the prostate, Cancer of Prostate, Cancer of the Prostate, Neoplasms, Prostate, Neoplasms, Prostatic, Prostate Cancer, Prostate Neoplasms, Prostatic Cancer

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Persons with Prostate, Bladder or Testicular Cancer.

Exclusion Criteria:

  • None

Sites / Locations

  • The Centre for Incurable Diseases

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

1

Arm Description

Outcomes

Primary Outcome Measures

The primary end point is to determine the therapeutic effects of far infrared radiation on Prostate Cancer.

Secondary Outcome Measures

The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other types of cancer (Bladder and Testis).

Full Information

First Posted
December 12, 2007
Last Updated
August 14, 2009
Sponsor
GAAD Medical Research Institute Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT00573820
Brief Title
Far Infrared Radiation Treatment for Prostate Cancer
Official Title
Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Prostate Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
August 2009
Overall Recruitment Status
Unknown status
Study Start Date
January 2006 (undefined)
Primary Completion Date
February 2008 (Actual)
Study Completion Date
December 2008 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
GAAD Medical Research Institute Inc.

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
A study to determine the use of far infrared radiation for the treatment of prostate cancer.
Detailed Description
Our initial assessment indicates that electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to cure a number of diseases, including prostate cancer.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prostatic Neoplasms
Keywords
Tumors or cancer of the prostate, Cancer of Prostate, Cancer of the Prostate, Neoplasms, Prostate, Neoplasms, Prostatic, Prostate Cancer, Prostate Neoplasms, Prostatic Cancer

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
4 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Other
Intervention Type
Radiation
Intervention Name(s)
Far Infrared Radiation
Intervention Description
Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each treatment session.
Primary Outcome Measure Information:
Title
The primary end point is to determine the therapeutic effects of far infrared radiation on Prostate Cancer.
Time Frame
2 years and 6 months
Secondary Outcome Measure Information:
Title
The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other types of cancer (Bladder and Testis).
Time Frame
2 years and 6 months

10. Eligibility

Sex
Male
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Persons with Prostate, Bladder or Testicular Cancer. Exclusion Criteria: None
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ken Nedd, M.D.
Organizational Affiliation
GAAD Medical Research Institute Inc.
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Kwasi Donyina, Ph.D.
Organizational Affiliation
GAAD Medical Research Institute Inc.
Official's Role
Study Director
Facility Information:
Facility Name
The Centre for Incurable Diseases
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4V 1L5
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Far Infrared Radiation Treatment for Prostate Cancer

We'll reach out to this number within 24 hrs